Pharmaceutical Outsourcing for Oral Development and Manufacturing
The oral solid dose (OSD) market is robust due to an increase in demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles. Oral solids continue to represent by far the largest category of pharmaceuticals manufactured today, driven in part by an increase in oncology treatments that require greater potency. With billions of capsules and tablets produced annually worldwide, oral solids remain the preferred route of drug administration due to their cost-effectiveness, relative ease of manufacturing, and patient-friendly dose form options.
|
